eISSN 2329-0358


Get your full text copy in PDF

Non-immunefactors in chronic rejection. Is there a role for hypolipemic drugs?

Leszek Paczek, Marta BiIl, Janusz Wyzgal, Liliana Gradowska, Zbigniew Galazka, Zbigniew Gaciong

Ann Transplant 1997; 2(2): 65-69

ID: 497163

The high prevalence of hypercholesterolemia in kidney transplant recipients probably contributes to the high cardiovascular mortality in these patients and may be a factor contributing to the progression of renal failure. We randomized 42 renal allograft recipients to receive low dose (20 mg) lovastatin or placebo for 32 weeks. All patients had stable graft function (serum creatinine level

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree